Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/29/2025

Blood Component Therapy in Trauma and Surgical Bleeding

Immediate Hemorrhage Control and Resuscitation Strategy

  • In patients with significant bleeding from trauma or surgery, immediately activate massive transfusion protocol with 1:1:1 ratio of RBC:FFP:platelets, administer tranexamic acid 1g IV within 3 hours of injury, and prioritize surgical hemorrhage control over laboratory-guided therapy 1, 2, 3
  • Early hemorrhage control is paramount, using temporary hemostatic devices followed immediately by surgical or interventional radiological control 1, 2, 3
  • Permissive hypotension during active bleeding, maintaining minimum acceptable preload without attempting to normalize blood pressure 1, 2, 3

Blood Component Administration Protocol

  • Administer RBC in 1:1 ratio with FFP during active hemorrhage 1, 2, 3
  • Administer FFP in 1:1 ratio with RBC during ongoing bleeding 1, 2, 3
  • Use cryoprecipitate when fibrinogen is critically low, giving two pools empirically during massive transfusion until test results available 1, 2, 3, 7
  • Maintain platelet count >50 × 10⁹/L during active bleeding, with higher targets in traumatic brain injury or multiple trauma 1, 2, 3, 8, 9

Tranexamic Acid Administration

  • Give tranexamic acid 1g IV immediately in trauma patients, within 3 hours of injury to reduce mortality 1, 2, 3, 4

Laboratory and Point-of-Care Testing

  • Use point-of-care testing to guide therapy once available, with viscoelastic testing recommended over traditional PT/APTT for real-time coagulation assessment 1, 2
  • Key laboratory targets once bleeding controlled include fibrinogen >1.5 g/L, platelet count >50 × 10⁹/L, and INR <1.5 5, 6, 8, 9

Critical Pitfalls to Avoid

  • Do not delay surgical hemorrhage control for laboratory results, delivering blood products empirically during active bleeding 1, 2, 3, 4
  • Do not attempt to normalize blood pressure with crystalloids, using blood products for volume replacement during hemorrhage 1, 2, 3, 4
  • Do not withhold tranexamic acid if within 3-hour window, as it must be given within 3 hours of injury to reduce mortality 1, 2, 3, 4

Temperature Management

  • Maintain normothermia aggressively, applying measures to reduce heat loss and warm hypothermic patients 1, 2, 3, 9